Edward J. Dulac III

Executive Vice President, Chief FinancialatIntellia Therapeutics· In proxies 2024–2025

Pay in FY2025-68% from the year before · Intellia Therapeutics stock -22.9% the same year

Edward J. Dulac III was paid $2.2M in FY2025 (Dec), down 68%. Intellia Therapeutics stock fell 22.9% that year.

Pay$100 in the stock at the end of FY23 → $29

Pay is from the Summary Compensation Table of each Intellia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Intellia TherapeuticsPublic company · 2 yr
- Executive Vice President, Chief Financial2024 – Present · 2 yrStock in role -59%

Roles come from the proxy statements of each company.

Activity

Pay
Intellia Therapeutics Executive Vice President, Chief Financial pay fell 68% to $2.2M. The stock fell 23% in FY2025 (Dec).
DEF 14AApr 30, 2026

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?